An observational study in Hip Dysplasia, sponsored by University of Utah. Completed. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2019-11-04.
Sponsored by University of Utah · Observational
The main objective of this study is to predict cartilage contact pressures in the hip after periacetabular osteotomy (PAO).
PAO was designed as a joint preserving surgical procedure to compensate for a shallow acetabulum by re-orienting the acetabulum into a position that provides better coverage of the femoral head. Although the overall theory that increasing load bearing area (improving coverage of the femoral head) results in reduced joint stress is intuitive, the complex bony surface may not behave in this manner. It is possible that joint stress may increase when the acetabulum is reoriented into a position that increases load bearing area if post-operative joint congruency is worse than pre-operative.
142 studies on the registry are indexed under Hip Dislocation; 34 are open to participants now.
This study's enrollment of 12 is below the median of 149 across 46 observational studies indexed under Hip Dislocation.
Browse Hip Dislocation studies →University of Utah is the lead sponsor of 991 studies on the registry; 177 are open to participants now.
Of its 111 completed or terminated interventional studies of FDA-regulated products, 64 (58%) have results posted.
Counted across the registry records on this site, refreshed daily.
18-40 years old
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
To predict cartilage contact pressures in the hip joint during simulated daily activities before and after periacetabular osteotomy (PAO) for correction of traditional dysplasia/retroversion.
Time frame: 1 year post surgery
No study locations are listed for this record.
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.